Search Results
Search for other papers by Eyun Song in
Google Scholar
PubMed
Search for other papers by Dong Eun Song in
Google Scholar
PubMed
Search for other papers by Jonghwa Ahn in
Google Scholar
PubMed
Search for other papers by Tae Yong Kim in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
lymph node metastases, and increased cancer-related mortality ( Kim et al. 2012 , Li et al. 2012 , Xing et al. 2013 ). Genetic alterations involving RAS -family genes comprise another distinct feature of DTCs ( Nikiforov 2008 , Prior et al
Search for other papers by Mírian Romitti in
Google Scholar
PubMed
Search for other papers by Simone Magagnin Wajner in
Google Scholar
PubMed
Search for other papers by Lucieli Ceolin in
Google Scholar
PubMed
Search for other papers by Carla Vaz Ferreira in
Google Scholar
PubMed
Search for other papers by Rafaela Vanin Pinto Ribeiro in
Google Scholar
PubMed
Search for other papers by Helena Cecin Rohenkohl in
Google Scholar
PubMed
Search for other papers by Shana de Souto Weber in
Google Scholar
PubMed
Search for other papers by Patrícia Luciana da Costa Lopez in
Google Scholar
PubMed
Search for other papers by Cesar Seigi Fuziwara in
Google Scholar
PubMed
Search for other papers by Edna Teruko Kimura in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
MAPK genetic alterations on the DIO3 levels in 25 human PTC samples. Clinical and oncological features are detailed in Table 1 . Mean age of patients was 37.04±14.7 years, and 76% were women. The median tumor size was 2.5 cm (0.8–10.5); 13 patients
Search for other papers by Jamie L Van Etten in
Google Scholar
PubMed
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
Department of Urology, University of Minnesota, Minneapolis, MN, USA
Search for other papers by Scott M Dehm in
Google Scholar
PubMed
Nowell in 1976 based on cytogenetic data ( Nowell 1976 ). In this early model, a cell of origin acquires genetic alterations that promote neoplasia. Further genetic instability fuels clonal expansion of “fit” clones that ultimately leads to advanced
Division of Endocrinology and Metabolism, Affilated Hospital of Qingdao University School of Medicine, The Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
Search for other papers by Yangang Wang in
Google Scholar
PubMed
Search for other papers by Meiju Ji in
Google Scholar
PubMed
Search for other papers by Wei Wang in
Google Scholar
PubMed
Search for other papers by Zhimin Miao in
Google Scholar
PubMed
Search for other papers by Peng Hou in
Google Scholar
PubMed
Search for other papers by Xinyan Chen in
Google Scholar
PubMed
Search for other papers by Feng Xu in
Google Scholar
PubMed
Search for other papers by Guangwu Zhu in
Google Scholar
PubMed
Search for other papers by Xianlu Sun in
Google Scholar
PubMed
Search for other papers by Yujun Li in
Google Scholar
PubMed
Search for other papers by Steven Condouris in
Google Scholar
PubMed
Search for other papers by Dingxie Liu in
Google Scholar
PubMed
Search for other papers by Shengli Yan in
Google Scholar
PubMed
Search for other papers by Jie Pan in
Google Scholar
PubMed
Search for other papers by Mingzhao Xing in
Google Scholar
PubMed
et al . 2006 ). This increase is virtually completely attributed to the diagnosis of papillary thyroid cancer (PTC), which accounts for ∼80% of all thyroid cancers. As in other human cancers, genetic alterations are the driving force for PTC
Search for other papers by Xiaoli Liu in
Google Scholar
PubMed
Search for other papers by Justin Bishop in
Google Scholar
PubMed
Search for other papers by Yuan Shan in
Google Scholar
PubMed
Search for other papers by Sara Pai in
Google Scholar
PubMed
Search for other papers by Dingxie Liu in
Google Scholar
PubMed
Search for other papers by Avaniyapuram Kannan Murugan in
Google Scholar
PubMed
Search for other papers by Hui Sun in
Google Scholar
PubMed
Search for other papers by Adel K El-Naggar in
Google Scholar
PubMed
Search for other papers by Mingzhao Xing in
Google Scholar
PubMed
, cancer-specific somatic genetic alterations, further supporting their potentially important role in human tumorigenesis. This is consistent with the previously observed increased telomerase activities in some human cancers ( Smekalova et al . 2012
Search for other papers by Jacob A Quaytman in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Elena Morariu in
Google Scholar
PubMed
( Nicholson et al. 2019 ). However, to take full advantage of molecular testing, more information is needed on the outcomes of thyroid nodules with various genetic alterations. The results of this study show that patients with isolated PTEN mutations are
Search for other papers by Kyle M Walsh in
Google Scholar
PubMed
Search for other papers by Murim Choi in
Google Scholar
PubMed
Search for other papers by Kjell Oberg in
Google Scholar
PubMed
Search for other papers by Matthew H Kulke in
Google Scholar
PubMed
Search for other papers by James C Yao in
Google Scholar
PubMed
Search for other papers by Chengqing Wu in
Google Scholar
PubMed
Search for other papers by Magdalena Jurkiewicz in
Google Scholar
PubMed
Search for other papers by Ling-I Hsu in
Google Scholar
PubMed
Search for other papers by Susanne M Hooshmand in
Google Scholar
PubMed
Search for other papers by Manal Hassan in
Google Scholar
PubMed
Search for other papers by Eva T Janson in
Google Scholar
PubMed
Search for other papers by Janet L Cunningham in
Google Scholar
PubMed
Search for other papers by Evan Vosburgh in
Google Scholar
PubMed
Search for other papers by Richard S Sackler in
Google Scholar
PubMed
Search for other papers by Richard P Lifton in
Google Scholar
PubMed
Search for other papers by Andrew T DeWan in
Google Scholar
PubMed
Search for other papers by Josephine Hoh in
Google Scholar
PubMed
list of the most commonly reported chromosomal alterations was compiled, and a meta-analysis of the prevalence of this alteration in patients with ileal carcinoids was performed. As different genetic alterations may distinguish localized ileal carcinoid
Search for other papers by Laura Sterian Ward in
Google Scholar
PubMed
possible markers, such as genetic alterations in NTRK, TERT , and the fusion of the striatin ( STRN ) gene and anaplastic lymphoma kinase ( ALK ) gene. The authors point to a series of molecular markers that may define a molecular signature, not only
Search for other papers by Nabahet Ameur in
Google Scholar
PubMed
CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit
Search for other papers by Ludovic Lacroix in
Google Scholar
PubMed
Search for other papers by Sophie Roucan in
Google Scholar
PubMed
Search for other papers by Véronique Roux in
Google Scholar
PubMed
Search for other papers by Sophie Broutin in
Google Scholar
PubMed
Search for other papers by Monique Talbot in
Google Scholar
PubMed
Search for other papers by Corinne Dupuy in
Google Scholar
PubMed
Search for other papers by Bernard Caillou in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
CNRS FRE 2939, Translational Research Laboratory, Department of Nuclear Medicine and Endocrine Oncology, Functional Genomic Unit
Search for other papers by Jean-Michel Bidart in
Google Scholar
PubMed
knowledge of induced genetic alterations in the various forms of MTC is essential for understanding the pathways involved in the development and progression of MTC with various phenotypes. It is also mandatory for the identification of molecular targets that
Search for other papers by Barbora Bulanova Pekova in
Google Scholar
PubMed
Search for other papers by Vlasta Sykorova in
Google Scholar
PubMed
Search for other papers by Karolina Mastnikova in
Google Scholar
PubMed
Search for other papers by Eliska Vaclavikova in
Google Scholar
PubMed
Search for other papers by Jitka Moravcova in
Google Scholar
PubMed
Search for other papers by Petr Vlcek in
Google Scholar
PubMed
Search for other papers by Lucie Lancova in
Google Scholar
PubMed
Search for other papers by Petr Lastuvka in
Google Scholar
PubMed
Search for other papers by Rami Katra in
Google Scholar
PubMed
Search for other papers by Petr Bavor in
Google Scholar
PubMed
Search for other papers by Daniela Kodetova in
Google Scholar
PubMed
Search for other papers by Martin Chovanec in
Google Scholar
PubMed
Search for other papers by Jana Drozenova in
Google Scholar
PubMed
Search for other papers by Radoslav Matej in
Google Scholar
PubMed
Search for other papers by Jaromir Astl in
Google Scholar
PubMed
Search for other papers by Jiri Hlozek in
Google Scholar
PubMed
Search for other papers by Petr Hrabal in
Google Scholar
PubMed
Search for other papers by Josef Vcelak in
Google Scholar
PubMed
Search for other papers by Bela Bendlova in
Google Scholar
PubMed
genetic alterations found in thyroid cancer includes different types of mutations: somatic point mutations, indels, copy number alterations, and fusion genes ( Nikiforov 2011 ). Among the fusion genes, the most common and best known are RET (rearranged